Auburn biotech firm manager fined for grant fraud

A former director of business affairs for an Auburn biotech firm was sentenced Friday in U.S. District Court in Seattle to the five days he already served in prison, three years of supervised release, 240 hours of community service and a $5,000 fine for making false statements.

Christopher K. Ma, 35, of Seattle, avoided prison time for faking an audit of $7.5 million in federal grants to his company. Ma was employed by Syntrix Biochip, Inc., DBA Syntrix Biosystems, Inc., when he knowingly submitted false audits to the National Institute of Health, which had provided substantial grant money to the firm.

Forfeiture proceedings over $41,000 in cash and some land in Auburn and two vehicles purchased by Ma remain pending.

At sentencing Chief U.S. District Judge Robert S. Lasnik said, “… instead of working it through with the agency, he (Ma) took the quick and fraudulent way out.”

Ma admitted fabricating a seven-page audit report for 2005.

Over the last seven years, the National Institute of Health (NIH) awarded the company $7.5 million in grants for cancer research. In July 2006, an NIH grants manager requested a copy of Syntrix’s audited financial statement, an audit that was required by NIH policy. After two weeks with no reply, the grants manager asked for the name of the audit firm in order to obtain the audit directly from the firm. The grants manager then received a seven-page report purporting to be an audit for 2005.

The subsequent investigation revealed that Ma had fabricated not only the audit, but the audit firm as well. Ma had used a pre-paid cell phone for the fake audit firm’s phone number, and he created false photocopies of checks to make it appear that the firm had been paid for the audit.

Ma also created fake e-mails to make it appear that he was corresponding with the firm about the audit. Additionally, Ma submitted to the NIH project ledgers that contained false entries, including entries pertaining to fictitious companies. The ledgers indicated various companies had been paid out of Syntrix funds, when if fact the money had gone to Ma for his personal use.

In requesting a prison term and fine, prosecutors wrote to the court noting, “the Court should account for the brazen nature of Mr. Ma’s conduct, and the extraordinary lengths that Mr. Ma undertook to attempt to deceive the NIH. Mr. Ma created a false audit report from whole cloth under the letterhead of a fictitious accounting firm. He composed fake e-mails and an invoice, and obtained a cell phone number for the purpose of making the fictitious accounting firm appear legitimate.”

Prosecutors added that Ma’s actions had created problems for Syntrix and one of Ma’s previous employers who had to demonstrate to the NIH that other funds had not been misused.

The case was investigated by Internal Revenue Service Criminal Investigations (IRS-CI) and the Department of Health and Human Services Office of Inspector General (HHS-OIG).